Viewing Study NCT02102204


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-02-19 @ 7:00 PM
Study NCT ID: NCT02102204
Status: COMPLETED
Last Update Posted: 2017-11-17
First Post: 2014-03-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis
Sponsor: Amgen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 20130213
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators